Abstract
Methods Forty females with ICPP received triptorelin 3.75 mg every 6 weeks subcutaneously injection in our hospital from 2002 to December 2010 and reached final height were collected. These patients were divided into two groups according to whether there was presence of growth deceleration and rhGH used concomitantly during the treatment. Group A: triptorelin alone, n=17; group B: triptorelin + rhGH, n=23. During the treatment, height, weight, annual GV, sexual development, PAH and adverse effects were observed. BA and height SDS were monitored yearly. After discontinuation of treatment, follow-up was continued for 4~9 years till final height was attained, and age of menarche, time of menarche from discontinuation were recorded.
Highlights
Forty females with ICPP received triptorelin 3.75 mg every 6 weeks subcutaneously injection in our hospital from 2002 to December 2010 and reached final height were collected. These patients were divided into two groups according to whether there was presence of growth deceleration and rhGH used concomitantly during the treatment
Follow-up was continued for 4~9 years till final height was attained, and age of menarche, time of menarche from discontinuation were recorded
International Journal of Pediatric Endocrinology 2015 2015(Suppl 1):P92
Summary
Yan Liang1*, Hong Wei[1], Jie Li2, Ling Hou[1], Jianling Zhang[1], Wei Wu1, Yanqin Ying[1], Xiaoping Luo[1]. From 8th APPES Biennial Scientific Meeting Darwin, Australia. Aims To evaluate the long-term efficacy of triptorelin 3.75 mg subcutaneously injection every 6 weeks on final height in girls with idiopathic central precocious puberty
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
